OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 11:10:10 03/06/2024 pm IST | ||
| 0.85 EUR | -1.16% |
|
| Current month | -1.16% | ||
| 1 month | +3.66% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.85 | -1.16% |
| 31/24/31 | 0.86 | -3.37% |
| 30/24/30 | 0.89 | -6.32% |
| 29/24/29 | 0.95 | +4.40% |
| 28/24/28 | 0.91 | +13.75% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 11:10 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK9NFF |
| ISIN | DE000UK9NFF3 |
| Date issued | 10/11/2022 |
| Strike | 398.9 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.23 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.81 € |
|---|---|
| Lowest since issue | 0.7 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- Certificat
